Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market, according to the Company’s website (www.PressureBioSciences.com). The video interview was recorded on Friday, May 20th, 2016 via Skype from SNN’s office in Los Angeles, CA and Pressure BioSciences’ headquarters in Boston, MA.
In this SNNLive Newscast, our host spoke with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc., and they discuss the following topics:
- Overview of Pressure BioSciences, Inc.
- What the company is selling and who is their target market
- Highlights of Q1 2016 Financials and business review
- Near-term goals for Q2-Q4 2016
For more information about Pressure BioSciences, Inc., please visit: www.PressureBiosciences.com
The interview may contain forward-looking statements about Pressure BioSciences, Inc. See Pressure BioSciences’ periodic filings with the Securities and Exchange Commission for more complete information.
© 2017 Stock News Now
Supported by Superior Web Solutions